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ABSTRACT 
 
This research investigated the in vivo (ZnCl2 27 mg/kg; CuSO4 10.2 mg/kg) and in vitro ef-
fects of zinc and copper on acetylcholinesterase activity of different cerebral areas, Zn and Cu 
levels in cerebrum, and body weight gain of young Wistar rats. Three-day-old rats were in-
jected (s.c.) with 5 doses (saline, Zn, Cu or Zn+Cu) for 5 consecutive days and were killed 24 
h after the last dose. In the other experiment, 7-day-old rats received only 1 dose (saline, Zn 
or Cu) and were killed at 1, 6 or 24 h after. For the in vitro experiments, the acetylcholi-
nesterase activity from cerebrum of 8-day-old rats was analyzed in presence of Zn or Cu (0.01 
to 1 mM). Regarding the in vivo experiments, only body weight gain was decreased by 5 si-
multaneous administrations of Zn and Cu. The acetylcholinesterase activity from cerebrum 
and cerebellum and cerebral zinc and copper contents were not altered by the treatments. In 
vitro, Cu 0.1 and 1 mM, but not Zn, inhibited the enzyme of both cerebrum and cerebellum. 
The enzymatic activity from cerebrum and cerebellum homogenate was more sensitive to Cu 
than the enzymatic activity from S2 and S1 fractions, respectively, since less metal was nec-
essary to inhibit the enzyme. 
 
Keywords: acetylcholinesterase; brain growth; cerebral metal levels; copper; suckling rats; 
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INTRODUCTION 
 
Zinc and copper trace elements are in-
volved in vital functions in mammalian 
tissues. Besides being structural compo-
nents of proteins, they are also co-factors 
for the activity of many enzymes that are 
required for growth, development and 
maintenance of the nervous system. These 
ions are also involved in the antioxidant 
defense, since they are part of enzymes, 
such as zinc/copper-superoxide dismutase 
(SOD). Furthermore, both ions function as 
signaling molecules that are released in 
synaptic terminals and act in membrane 
proteins playing modulator role in regulat-
ing neuronal excitability (Mathie et al., 
2006). 
It is known that the concentration of 
zinc in brain is higher than in other organs, 
around 150 µM (about 10-fold serum zinc 
levels). As this metal is involved in the be-
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havior and cognitive function, zinc defi-
ciency may lead to alterations in brain ac-
tivity, motor development, neuropsy-
chological behavior, attention, learning, and 
memory (Mocchegiani et al., 2005).  
Despite the highest concentration of 
copper being in liver (Gaetke and Chow, 
2003), it is also found in the nervous system 
reaching concentrations around 70 µM in 
the cerebrospinal fluid and 200 µM in the 
synaptic cleft (Mathie et al., 2006). Neuro-
logical and neuropsychological symptoms 
of copper toxicity occur during the Wil-
son’s disease development (Strausak et al., 
2001). Copper homeostasis alteration in 
brain is an important possible factor in the 
etiology of Alzheimer’s disease (Camakaris 
et al., 1999), since the copper concentration 
may attain 400 µM in this neurodegenera-
tive disease (Mathie et al., 2006).  
Acetylcholine, the principal neuro-
transmitter of the cholinergic neurons, is 
one of the main neurotransmitters involved 
in neurodegenerative diseases (Wacker et 
al., 2005) and is related to cognitive func-
tions involved in the learning and memory 
process (Blockland, 1995). Cholinergic 
neurons correspond to 25 % of the brain 
cells and are represented mainly by cortical 
and hippocampal neurons (Wacker et al. 
2005). Moreover, hypothalamus and cere-
bellum, among others, are also cerebral 
areas supplied by cholinergic projection 
neurons (Das et al., 2001). 
The synaptic cholinergic transmission 
depends on the acetylcholinesterase (AChE) 
(E.C.3.1.1.7) activity, since this enzyme 
promotes the hydrolysis of the neurotrans-
mitter acetylcholine in choline and acetic 
acid, resulting in the terminus of the trans-
mission of the nervous impulse in the syn-
apses (Taylor, 1996). In the mammalian 
brain, AChE exists in different globular 
forms, mainly as mono-, di- and tetramers 
of catalytic subunits (G1, G2, G4). These 
forms can be classified according to the 
solubility in salt (G1, cytosolic and water 
soluble) and detergent (G4, membrane 
bound) (Nigg and Knaak, 2000; Rieger and 
Vigny, 1976). 
AChE is used as a biomarker of the cho-
linergic function, since its activity is inhib-
ited by different toxic agents, such as pesti-
cides (Taylor, 1996) and heavy metals (Na-
jimi et al., 1997; Frasco et al., 2007). How-
ever, the effects of zinc and copper on the 
AChE activity are little known and some-
times contradictory. The brain enzyme of 
fish is inhibited by zinc (Suresh et al. 1992) 
and activated by copper (Romani et al., 
2003). The brain AChE of rats may be ei-
ther decreased (Brocardo et al., 2005) or 
increased by zinc (Carageorgiou et al., 
2005) and increased by cadmium (Cara-
georgiou et al., 2005). Nevertheless, the 
effects of these metals on AChE from 
young rats are unknown. This is of interest 
since animals in development are particu-
larly sensitive to extern insults such as nu-
tritional privation (Rocha et al., 1993; Ven-
dite et al., 1985) and heavy metal (Peixoto 
et al., 2003; Peixoto and Pereira, 2007; 
Roza et al., 2005; Franciscato et al., 2009). 
This high sensitivity is due to the fact that 
rodents have a high growth and develop-
ment of brain and organs during the first 
days of life. Thus, the developmental neu-
rotoxicity with consequent neurodevelop-
mental disorders and subclinical brain dys-
function may be associated with the in-
creasing risk of neurodegenerative diseases 
(Grandjean and Landrigan, 2006). 
Considering the special sensitivity of 
young rats, this study aimed to investigate 
the effects of zinc and copper exposure on 
the AChE activity of different cerebral ar-
eas, brain metal levels and physiological 
parameters as well as to verify the action of 
these metals on the AChE activity in vitro.  
 
MATERIALS AND METHODS 
 
Chemicals  
Acetylthiocholine iodide (ATC), 5-5-
dithiobisnitrobenzoic acid (DTNB), Tris 
(hydroxymethyl-d3) amino-d2–methane, 
Coomassie brilliant blue G and bovine se-
rum albumin were obtained from Sigma 
Chemical Co. (St. Louis, MO, USA), and 
zinc chloride (ZnCl2), pentahydrate copper 
sulfate (CuSO4.5H2O), potassium phos-
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phate dibasic (K2HPO4) and monobasic 
(KH2PO4), sodium phosphate dibasic 
(Na2HPO4), sucrose, Triton X-100, and 
nitric acid were obtained from Merck 
(Darmstadt, Germany).  
 
Animals 
Studies were conducted in accordance 
with the national and institutional guide-
lines (University Ethics Committee Guide-
lines — Process number 23081.013915/2004-06) 
for experiments with animals. Wistar preg-
nant rats obtained from the General Animal 
House of the Federal University of Santa 
Maria were transferred to the colony room 
and maintained individually in opaque plas-
tic cages on a 12 h light–dark cycle at a 
controlled temperature (23 ± 2° C). One 
day after birth, the number of pups of each 
litter was reduced to 9. Males and females 
were used without distinction. 
 
Treatment schedules 
1. Five doses of zinc and/or copper: 
From the 3rd to 7th day of life, rats re-
ceived one daily dose of treatment, admin-
istered by subcutaneous (s.c.) injections in a 
constant volume of 10 ml/kg body weight. 
Animals were weighed daily to adjust the 
dose.  
Copper curve: four litters were used and 
the rats of each litter were divided into 
4 groups of treatment: saline (NaCl 150 mM); 
5.1 mg/kg CuSO4.H2O (1.3 mg/kg Cu); 
10.2 mg/kg CuSO4.5H2O (2.6 mg/kg Cu) 
and 20.4 mg/kg CuSO4.5H2O (5.2 mg/kg Cu). 
Zinc and copper treatments: five litters 
were used and the rats were divided into 4 
groups: saline (NaCl 150 mM); 27 mg/kg 
ZnCl2 (12.9 mg/kg Zn); 10.2 mg/kg Cu-
SO4.5H2O (2.6 mg/kg Cu) and 27 mg/kg 
ZnCl2 + 10.2 mg/kg CuSO4.5H2O 
(12.9 mg/kg Zn + 2.6 mg/kg Cu). 
Each litter contained two rats for each 
treatment. 
 
2. One dose of zinc or copper: 
Seven-day-old rats received one dose of 
treatment, administered by subcutaneous 
(s.c.) injections in a constant volume of 
10 ml/kg body weight. Three litters were 
used and each litter was divided into 3 treat-
ments: saline (NaCl 150 mM); 27 mg/kg 
ZnCl2 (12.9 mg/kg Zn) and 10.2 mg/kg 
CuSO4.5H2O (2.6 mg/kg Cu). 
 
Tissue preparation  
Rats that received five doses of treat-
ments were killed 24 h after the last dose 
and rats that received one dose were killed 
at 1, 6 or 24 h after treatment. 
Brain was removed and cerebrum and 
cerebellum were dissected on ice. For metal 
content determination, cerebrum and cere-
bellum were weighed, placed in vials, and 
frozen at -20° C until analysis. For the de-
termination of the AChE activity, cerebrum 
and cerebellum were homogenized (1:10, 
w/v) in 10 mM Tris-HCl buffer, pH 7.2 
with 160 mM sucrose. Homogenates were 
frozen at -20° C until analysis.  
 
Enzyme assay 
  The AChE activity was determined 
by the method of Ellman et al. (1961), 
modified as described in Pereira et al. 
(2004). The mixture assay contained DTNB 
1.04 mM, potassium phosphate buffer 
24 mM pH 7.2 and 25 µL of enzymatic 
material. It was pre-incubated for 2 min at 
30º C and the reaction was started with the 
addition of acetylthiocholine (ATC) 
0.83 mM. The product of thiocholine reac-
tion with DTNB was determined at 412 nm 
every 30 sec during 2 min. The specific 
activity was expressed as µmol ATC hydro-
lyzed/h/mg protein. All samples were run in 
triplicate. 
 
Protein determination  
Protein concentrations in the samples 
were determined by the Coomassie blue 
method (Bradford, 1976) using bovine se-
rum albumin as a standard. All samples 
were run in triplicate.  
 
Metal content determination 
The determination of cerebral zinc and 
copper contents was made by Inductively 
Coupled Plasma Optical Emission Spec-
troscopy (ICP-OES) as described in detail 
in Peixoto et al. (2008). Samples were di-
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141 
gested using a Model Multiwave 3000 mi-
crowave oven equipped with high-pressure 
quartz vessels (80 bar, 250 °C, Anton Paar, 
Graz, Austria). Zinc and copper contents 
are expressed as µg of metal/g wet tissue. 
 
In vitro zinc and copper assays 
Brain of 8-day-old rats was removed 
and cerebrum, cerebellum hippocampus and 
hypothalamus were dissected, weighed and 
homogenized. For the determination of the 
AChE activity in fractions of cerebrum and 
cerebellum, homogenate aliquots (H) were 
separated and the remaining homogenates 
were centrifuged at 14,500 g for 30 min at 
4o C for the separation of the salt soluble 
fraction present in the supernatant (S1). The 
pellet was suspended in a mixture of 1 % 
Triton X-100 and 50 mM sodium phosphate 
buffer, pH 7.2. The suspension was agitated 
for 10 min at 10o C in ice bath. Afterwards, 
it was centrifuged at 23,400 g for 30 min at 
4o C for the separation of the detergent solu-
ble fraction present in the supernatant (S2) 
(Das et al., 2001). 
Zinc and copper were tested varying fi-
nal concentrations from 0.01 to 1 mM. The 
metals were pre-incubated with the enzyme 
for 2 min, and the enzymatic reaction was 
conduced similarly to in vivo enzymatic 
assays. The AChE activity is expressed as 
delta extinction/min (∆E/min). The concen-
tration of the metal required to induce 50 % 
inhibition of the AChE activity (IC50) was 
calculated according to Dixon method (1/V 
versus [I]) (Dixon and Webb, 1964). 
 
Statistical analysis 
Results were analyzed by one- or two-
way ANOVA followed by Duncan’s multi-
ple range test or paired Student t-test when 
appropriate. 
 
RESULTS 
 
Copper curve 
Results demonstrated that the treatments 
with the different doses of copper (1.3, 2.6 
or 5.2 mg/kg) did not alter the body weight. 
All groups presented significant increase of 
weight from the initial to the end of the 
treatment [two-way ANOVA (4 treatments 
x 2 days): F(1,14)=729.24, p<0.001]. The 
cerebrum weight was not modified by the 
treatments (one-way ANOVA) (data not 
shown). However, the highest dose caused 
lesions in the skin at the site of the injec-
tion. Thus, the intermediate dose of the 
copper was chosen for the experiments with 
zinc and copper. 
 
Treatments with five doses of zinc and/or 
copper 
Effects of the treatments with saline, 
12.9 mg/kg Zn, 2.6 mg/kg Cu or both on 
body weight gain are showed in Figure 1. 
Two-way ANOVA (4 treatments x 6 days) 
revealed a significant effect of days 
[F(5,80)=421.04, p<0.001] and treatments x 
days interaction [F(15,80)=9.61, p<0.001]. 
The interaction was significant since 
Zn+Cu animals had lower weight gain than 
the other groups. In fact, on day 8 (24 h 
after the last dose) the Zn+Cu group pre-
sented smaller body weight than the others 
(one-way ANOVA, F(3,16)=3.35 p<0.05) 
(see Table 1). 
Figure 1: Body weight of rats (n=5) treated for 
five consecutive days (from the 3rd to 7th day of 
age) with saline, 12.9 mg/kg Zn, 2.6 mg/kg Cu 
or 12.9 mg/kg Zn + 2.6 mg/kg Cu. Results are 
presented as mean ± SEM.  
(*) Significant difference from the other groups: 
p<0.05 (Duncan’s multiple range test) 
 
Cerebrum and cerebellum weight, and 
cerebrum/body and cerebellum/body weight 
ratios are shown in Table 1. These parame-
ters were not significantly altered by the 
treatments (one-way ANOVA).  
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Table 1: Body, cerebrum and cerebellum weights at 24 h after the last dose (8 days old), and relation 
between weights of brain/body and cerebellum/body of rats treated (s.c.) for five consecutive days with 
saline, 12.9 mg/kg Zn, 2.6 mg/kg Cu or 12.9 mg/kg Zn + 2.6 mg/kg Cu. 
 Weight (g) Relative weight (%) 
Treatment Body Cerebrum Cerebellum Cerebrum/Body Cerebellum/Body 
Saline 17.68 ± 1.74 0.53 ± 0.04 0.13 ± 0.004 2.99 ± 0.07 0.76 ± 0.06 
Zn 16.66 ± 1.17 0.48 ± 0.03 0.11 ± 0.01 2.95 ± 0.01 0.64 ± 0.07 
Cu 17.68 ± 1.38 0.49 ± 0.03 0.12 ± 0.01 2.81 ± 0.06 0.66 ± 0.04 
Zn + Cu 12.78 ± 0.43* 0.42 ± 0.03 0.09 ± 0.01 3.19 ± 0.02 0.74 ± 0.06 
Results are presented as mean ± SEM, n=5.  
(*) Significant difference from the other groups in the same column: p<0.05 (Duncan’s multiple range 
test) 
 
Cerebrum and cerebellum AChE activi-
ties and cerebral zinc and copper contents 
are showed in Table 2. The treatments with 
zinc and/or copper modified neither the 
AChE activity from cerebrum and cerebel-
lum homogenate nor the zinc and copper 
cerebral contents (one-way ANOVA).  
 
Treatments with one dose of zinc or copper  
Cerebrum and cerebellum AChE activi-
ties are showed in Table 3. Zinc and copper 
did not modify the enzymatic activity when 
animals were killed 1, 6 or 24 h after the 
injection of the metal (one-way ANOVA). 
 
Table 2: Cerebrum and cerebellum AChE activities and zinc and copper concentrations in cerebrum 
of rats treated (s.c.) for five consecutive days with saline, 12.9 mg/kg Zn, 2.6 mg/kg Cu or 12.9 mg/kg 
Zn + 2.6 mg/kg Cu.  
 AChE activity Metal contents (µg/g) 
Treatment Cerebrum Cerebellum Cu Zn 
Saline 2.36 ± 0.09 2.72 ± 0.13 0.99 ± 0.02 9.60 ± 0.15 
Zn 2.61 ± 0.29 3.63 ± 0.25 0.92 ± 0.02 9.38 ± 0.27 
Cu 2.67 ± 0.27 3.41 ± 0.29 1.07 ± 0.05 9.50 ± 0.40 
Zn + Cu 2.09 ± 0.18 3.13 ± 0.23 0.96 ± 0.03 9.56 ± 0.20 
Specific enzyme activity is expressed as µmol ATC hydrolyzed/h/mg protein (n=5). Metal content is 
expressed as µg/g wet tissue (n=3). Results are presented as mean ± SEM. 
 
Table 3: Cerebrum and cerebellum AChE activities of rats treated (s.c.) with 1 dose of saline, 
12.9 mg/kg Zn or 2.6 mg/kg Cu and killed 1, 6 or 24 h after injection 
  AChE activity  
Intervals after injection 
Tissue Treatment 1 h 6 h 24 h 
Saline 2.17 ± 0.15 1.91 ± 0.14 1.85 ± 0.32 
Zn 1.92 ± 0.11 2.41 ± 0.66 2.45 ± 0.58 
 
Cerebrum 
Cu 2.41 ± 0.62 1.67 ± 0.66 1.86 ± 0.29 
Saline 2.21 ± 0.24 2.59 ± 0.49 2.79 ± 0.56 
Zn 2.69 ± 0.13 1.67 ± 0.34 1.67 ± 0.34 
 
Cerebellum 
Cu 2.45 ± 0.64 2.29 ± 0.32 2.07 ± 0.17 
The enzyme activity is expressed as µmol ATC hydrolyzed/h/mg protein. Results are presented as 
mean ± SEM (n=3). 
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Zinc and copper in vitro effects 
In vitro effects of zinc and copper (0.01 
to 1 mM) on the AChE activity of cerebrum 
and cerebellum are presented in Figure 2A 
and B. Two-way ANOVA (tissues x metal 
concentrations) revealed a significant effect 
of copper [F(4,24)=29.69, p<0.001] but not 
of zinc. Copper at 0.1 and 1 mM inhibited 
the AChE activity of both cerebrum [0.1 
mM, t(3)=4.90, p<0.02; 1 mM, t(3)=8.19, 
p<0.04] and cerebellum [0.1 mM, 
t(3)=3.52, p<0.04; 1 mM, t(3)=6.16, 
p<0.009] homogenates. However, no dif-
ference between the tissues was found.  
 
Figure 2: In vitro effects of different concentra-
tions of zinc (A) and copper (B) on the AChE 
activity of rat cerebrum and cerebellum homo-
genates. Results are presented as mean ± 
SEM, n=4.  
(*) Significant difference from 0 mM: p<0.05 
(paired t-test). 
 
IC50 of copper for AChE from cere-
brum, cerebellum, hippocampus and hypo-
thalamus homogenates were similar (one-
way ANOVA): 0.30 ± 0.05, 0.37 ± 0.05, 
0.35 ± 0.07 and 0.24 ± 0.05 mM, respec-
tively. 
IC50 of copper for AChE from cerebrum 
and cerebellum cellular fractions are shown 
in Figure 3. Two-way ANOVA (2 tissues x 
3 fractions) revealed a significant effect of 
fractions [F(2,12)=6.22, p<0.05]. To cere-
brum, the IC50 for AChE S2 fraction was 
significantly [t(3)=-4.28 p<0.05] higher 
than IC50 for AChE  homogenate, while to 
cerebellum IC50 for AChE S1 fraction was 
significantly [t(3)=-4.14 p<0.05] higher 
than IC50 for AChE homogenate (paired t-
test). 
 
Figure 3: IC50 of CuSO4.5H2O for in vitro inhibi-
tion of the AChE activity of brain and cerebel-
lum homogenates, S1 and S2 fractions. Results 
are presented as mean ± SEM of metal concen-
tration required to induce 50% inhibition of the 
AChE activity, n=4. Different letters confer sig-
nificant statistical difference with p<0.05 
(paired-t test). 
 
DISCUSSION 
Zinc and copper are essential trace ele-
ments for the development and maintenance 
of the cerebral function; nevertheless, when 
in excess both may be neurotoxic (Mathie 
et al., 2006). The equilibrium between the 
two metal levels seems to be fundamental 
to several neurological functions (Barnham 
et al., 2004). However, there is a lack of 
studies on the effects of essential metals on 
young animals. Thus, in this study we in-
vestigated if the cholinergic systems 
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through the AChE activity of lactating rats 
were sensitive to zinc and copper exposure. 
Before testing the relationship between 
the two metals, it was necessary to deter-
mine the higher dose of copper inert in in-
ducing any general physiologic parameter 
damage inspected by both visual observa-
tion and corporal development. This deter-
mination is important since the zinc dose 
chosen has no damaging effect and still 
prevents several toxic effects of mercury 
(Peixoto et al., 2003; Peixoto and Pereira, 
2007; Franciscato et al., 2009). Thus, the 
animals were submitted to copper dose 
curve to search the highest dose inert in 
inducing any toxic effect that could be used 
in further studies, as zinc is used in preven-
tive treatments (Peixoto et al., 2003; 
Peixoto and Pereira, 2007; Franciscato et 
al., 2009). We could observe that although 
the highest dose tested did not alter the 
body and brain weight, it caused lesions in 
the skin at the site of the injection. Thus, 
based on the findings we have chosen the 
intermediate dose of the copper curve to 
carry out the experiments with zinc and 
copper. 
Whereas zinc or copper treatments 
modified neither the body weight gain nor 
cerebrum and cerebellum weights, the si-
multaneous administration of the two met-
als for five consecutive days induced a de-
crease in the body weight gain (Figure 1) 
and a slight, but not significant, reduction 
of cerebrum and cerebellum weight (Table 
1). Our results agree with those obtained by 
Smith et al. (1997) that found a decrease in 
the growth of pigs fed on a diet with zinc 
and copper addition, but not supplemented 
only with zinc. According to these authors, 
the decrease in the development may be due 
to an inhibition of nutrient metabolism. In 
fact, an imbalance between these two met-
als may lead to peripheral metabolic toxic 
effects (Klevay, 1973). Furthermore, the 
effects of Zn+Cu administration on body, 
cerebrum and cerebellum weights were 
simultaneous since the ratios between two 
parameters were also similar (Table 1). 
Zinc and copper are important ions in-
volved in the neurotransmission process 
(Smart et al. 2004). Both may act as neu-
romodulators in the excitatory synapses 
(Mathie et al., 2006; Mocchegiani et al., 
2005). Alterations in zinc and copper ho-
meostasis have been reported in neurode-
generative diseases due to the interaction of 
metals with key proteins and subsequent 
induction of oxidative stress leading to neu-
rodegeneration (Barnham et al., 2004). In 
this study, the exposure to zinc and/or cop-
per produced no changes on the AChE ac-
tivity of cerebrum and cerebellum (Table 
2). These results differ from those reported 
by Brocardo et al. (2005) that found a de-
crease in the AChE activity of cerebral cor-
tex and hippocampus of adult rats treated 
with one dose of ZnCl2 (5 mg/kg), as well 
as from those by Romani et al. (2003) that 
related an increase of the AChE activity of 
brain and muscle of fish exposed to sub-
lethal concentrations of CuSO4. Differences 
among the results may be related to the age 
of the animals treated with zinc and to the 
species of animals exposed to copper, re-
spectively. Furthermore, it was possible to 
observe that the simultaneous exposure to 
the two metals did not alter the enzyme 
activity. The absence of effects on the 
AChE activity was accompanied by the 
absence in the variation of zinc and copper 
contents in cerebrum and cerebellum. Simi-
lar levels of these metals among groups 
may be due to the rapid metal redistribu-
tions (Komsta-Szumska and Chmielnicka, 
1983). In fact, in a recent study we ob-
served that zinc treatment (same schedule 
of treatment) causes a high accumulation of 
this metal in liver and in kidney, without 
alteration in blood levels (Peixoto et al., 
2008).  
With the objective to investigate if the 
absence of the effect of zinc and/or copper 
could be due to the interval in which the 
animals were killed after the treatment 
(24 h after the last dose), other animals 
were sacrificed 1, 6 or 24 h after treatment. 
The results of this experiment showed that 
the brain enzyme activity was not altered in 
any of the intervals (Table 3), confirming 
that these metals, in the doses used, did not 
modify the AChE activity. 
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Results obtained with in vivo experi-
ments have shown that, although the young 
animals are very sensitive to different ex-
tern insults (Peixoto et al., 2003; Rocha et 
al., 1993; Roza et al., 2005; Vendite et al., 
1985) due to accelerated growth and devel-
opment of brain (Gottlieb et al., 1977), the 
doses of zinc and copper used in this study 
were not sufficient to cause accumulation of 
these metals in the central nervous system 
nor to produce damage to cholinergic sys-
tem when considered the AChE activity as 
biomarker in suckling rats.  
We also studied the in vitro effects of 
zinc and copper on the AChE activity of 
cerebrum and cerebellum of rats of the 
same age used in the in vivo study. Copper 
0.1 and 1 mM inhibited the AChE activity 
of both cerebrum (45 % and 68 %) and 
cerebellum (48 % and 79 %) (Figure 2A 
and 2B). The absence of zinc in vitro ef-
fects on brain AChE activity is in accor-
dance with the results obtained by Senger et 
al. (2006) who reported that zinc does not 
affect this enzyme activity from brain of 
zebrafish. The AChE copper inhibition may 
be due to an action of Cu2+ on the catalytic 
site of the enzyme by an electrostatic inter-
action involving specific aminoacidic resi-
dues in the active site (Berman and Leo-
nard, 1990). However, studies with enzy-
matic kinetic are necessary to sustain this 
hypothesis.   
Considering that only copper was effec-
tive in inhibiting the cerebral AChE activ-
ity, the concentration of copper necessary to 
inhibit 50 % (IC50) of the enzyme activity 
of cerebrum, cerebellum, hypothalamus and 
hippocampus was evaluated and we found a 
similar IC50 for AChE of these structures. 
Analyzing the sensitivity of AChE of sub-
cellular fractions enriched with G4 globular 
form (membrane bound form; S2 fraction) 
or with G1 globular form (cytosolic form, 
S1 fraction) (Nigg and Knaak, 2000; Rieger 
and Vigny, 1976) and comparing these ac-
tivities with the activity from total homoge-
nate, we observed that S2 fraction from 
cerebrum and S1 fraction from cerebellum 
were less sensitive to the inhibitor than the 
mixture of these forms contained in the 
homogenate, since a higher Cu concentra-
tion to inhibit 50 % of enzyme activity 
(Figure 3) was necessary. These results 
suggest that the residual activity (pellet 2) 
in the fraction not evaluated but present in 
the total homogenate seems to be the most 
vulnerable to inhibitory effects of copper. 
Specific experiments are necessary to fun-
dament this hypothesis. However, this sup-
position does not interfere in the absence of 
the metal effects in vivo since the enzyme 
activity was analyzed in total homogenate. 
In conclusion, although the simultane-
ous administration of zinc and copper 
caused a decrease in the body weight gain, 
these metals separately did not alter the 
cerebral and corporal development. Zinc 
and copper treatment did not change the 
cerebral AChE activity and zinc and copper 
contents; whereas in vitro high concentra-
tions of copper decreased the cerebrum and 
cerebellum AChE activity. Despite the in 
vitro results, the absence of in vivo effects 
permits to suggest that copper may be in-
vestigated as a possible preventive essential 
metal to toxic effects of the heavy metals as 
observed to zinc (Peixoto et al. 2003, 2008; 
Peixoto and Pereira 2007; Franciscato et al., 
2009).  
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